Literature DB >> 24836468

International variation in lung cancer mortality rates and trends among women.

Lindsey A Torre1, Rebecca L Siegel2, Elizabeth M Ward2, Ahmedin Jemal2.   

Abstract

BACKGROUND: There is no recent comprehensive global analysis of lung cancer mortality in women. We describe contemporary mortality rates and trends among women globally.
METHODS: We used the World Health Organization's Cancer Mortality Database covering 65 populations on six continents to calculate age-standardized (1960 Segi world standard) lung cancer death rates during 2006 to 2010 and annual percent change in rates for available years from 1985 to 2011 and for the most recent five data years by population and age group (30-49 and 50-74 years).
RESULTS: Lung cancer mortality rates (per 100,000) among young women (30-49 years) during 2006 to 2010 ranged from 0.7 in Costa Rica to 14.8 in Hungary. Rates among young women were stable or declining in 47 of 52 populations examined. Rates among women 50 to 74 years ranged from 8.8 in Georgia and Egypt to 120.0 in Scotland. In both age groups, rates were highest in parts of Europe (Scotland, Hungary, Denmark) and North America and lowest in Africa, Asia, and Latin America. Rates in older women were increasing for more than half (36/64) of populations examined, including most countries in Southern, Eastern, and Western Europe and South America.
CONCLUSIONS: Although widespread reductions in lung cancer in young women provide evidence of tobacco control success, rates continue to increase among older women in many countries. IMPACT: More concentrated efforts to initiate or expand tobacco control programs in these countries globally will be required to attenuate the future lung cancer burden. Cancer Epidemiol Biomarkers Prev; 23(6); 1025-36. ©2014 AACR. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 24836468     DOI: 10.1158/1055-9965.EPI-13-1220

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

1.  Perioperative outcome of lung cancer surgery in women: results from a Spanish nationwide prospective cohort study.

Authors:  Juan J Fibla; Laureano Molins; Florencio Quero; José Miguel Izquierdo; David Sánchez; Jorge Hernández; Clara Bayarri; Marc Boada; Ángela Guirao; Antonio Cueto
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

2.  Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER-Medicare Database Analysis.

Authors:  Bassel Nazha; Chao Zhang; Zhengjia Chen; Camille Ragin; Taofeek K Owonikoko
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 3.  Global trends of lung cancer mortality and smoking prevalence.

Authors:  Farhad Islami; Lindsey A Torre; Ahmedin Jemal
Journal:  Transl Lung Cancer Res       Date:  2015-08

4.  Using the New CellCollector to Capture Circulating Tumor Cells from Blood in Different Groups of Pulmonary Disease: A Cohort Study.

Authors:  Yutong He; Jin Shi; Gaofeng Shi; Xiaoli Xu; Qingyi Liu; Congmin Liu; Zhaoyu Gao; Jiaoteng Bai; Baoen Shan
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

5.  Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010.

Authors:  Bochen Cao; Freddie Bray; Hiram Beltrán-Sánchez; Ophira Ginsburg; Samir Soneji; Isabelle Soerjomataram
Journal:  BMJ       Date:  2017-06-21

Review 6.  Global Epidemiology of Lung Cancer.

Authors:  Julie A Barta; Charles A Powell; Juan P Wisnivesky
Journal:  Ann Glob Health       Date:  2019-01-22       Impact factor: 2.462

7.  Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells.

Authors:  Erying Zhang; Xiaowei Feng; Fei Liu; Peihua Zhang; Jie Liang; Xudong Tang
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

8.  Age- and Sex-Specific Trends in Lung Cancer Mortality over 62 Years in a Nation with a Low Effort in Cancer Prevention.

Authors:  Ulrich John; Monika Hanke
Journal:  Int J Environ Res Public Health       Date:  2016-03-25       Impact factor: 3.390

9.  Lung cancer mortality and years of potential life lost among males and females over six decades in a country with high smoking prevalence: an observational study.

Authors:  Ulrich John; Monika Hanke
Journal:  BMC Cancer       Date:  2015-11-09       Impact factor: 4.430

10.  Analysis of the expression levels and clinical value of miR-365 and miR-25 in serum of patients with non-small cell lung cancer.

Authors:  Dongxuan Huang; Wenfang Ou; Huifen Tong; Ming Peng; Yamei Ou; Zeqing Song
Journal:  Oncol Lett       Date:  2020-09-03       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.